Tuesday, November 4, 2014

Hot Quality Stocks To Invest In 2014

The past two- and five-year periods haven't been kind to the land drilling industry, but Helmerich & Payne (NYSE:HP) has fared quite a bit better than most. While rivals like Nabors (NYSE:NBR), Patterson-UTI (Nasdaq:PTEN), Precision Drilling (NYSE:PDS), and Pioneer Energy (NYSE:PES) have seen their shares decline from between 30% and 70% over the last two to five years, Helmerich & Payne is close to breakeven.

HP owes its success to a program of focused differentiation ��namely, building high-spec rigs that not enable operators to drill the horizontal wells that are increasingly necessary to exploit oil and gas reservoirs, but to do so faster and with fewer drilling days. A significant recent increase in the dividend has demonstrated management's willingness to share success with shareholders, but the quality of this company is never far from the minds of Wall Street. Consequently, the shares don't look like a tremendous bargain today.

Becoming A Leader By Leading

Top 5 Computer Hardware Companies To Buy Right Now: Digital Ally Inc.(DGLY)

Digital Ally, Inc. engages in the production and sale of digital video imaging, audio/video recording, storage, and other products for use in law enforcement and security applications. Its digital audio/video recording and storage product line comprises an in-car digital audio/video system that is integrated into a rear view mirror; an all-weather mobile digital audio/video system designed for motorcycle, ATV, and boat uses; a miniature body-worn digital audio/video camera; a hand-held speed detection system based on light detection and ranging (LIDAR); a hand-held thermal imaging camera used for improved night vision; and a digital audio/video system, which is integrated into a law-enforcement style flashlight. The company?s products make self-contained video and audio recordings onto flash memory cards that are incorporated in the body of the digital video rear view mirror, officer-worn video, and audio system and flashlight. Digital Ally, Inc. sells its products to law enforcement agencies and other security organizations, as well as for consumer and commercial applications through direct sales and third-party distributors. The company is based in Overland Park, Kansas.

Advisors' Opinion:
  • [By Bryan Murphy]

    Back on August 29th, I had the unfortunate job of explaining that the Digital Ally, Inc. (NASDAQ:DGLY) rally had likely run most - if not all - of its course, and DGLY shares were poised to move lower..... soon, and a lot. It wasn't a particularly popular idea to float to the investing public, many of whom had just purchased Digital Ally on the way up, in the wake of the St. Louis riots. That social unrest put the spotlight on the need for security tools like the ones supplied by DGLY, and once thrust into the limelight, the sky was the limit with new-found notoriety. Anyone who even suggested the stock could do anything but go up from there was clearly a lunatic.

  • [By James E. Brumley]

    There's no denying Tesla Motors Inc. (NASDAQ:TSLA) has been one of year's top investment stories, with shares running up from less than $40 to more than $194 in just a few short months. But, as one might imagine, that 385% runup from TSLA creates something of a disconnect between the company and its share price. Time to head for the exit. Instead, a better use of that now-considerably-greater capital is a position in Digital Ally, Inc. (NASDAQ:DGLY) ... a stock that's also had a pretty good 2014, but has suffered more than a small setback since mid-September. Specifically, DGLY has pulled back from a peak price of $17.47 to a low of $9.88 as of Friday. But, it looks like that correction may have already come to an end.

Hot Quality Stocks To Invest In 2014: AEterna Zentaris Inc.(AEZS)

Aeterna Zentaris Inc. operates as a late-stage drug development company specialized in oncology and endocrine therapy. Its lead oncology compounds include perifosine, a PI3K/Akt pathway inhibitor that is in Phase 3 registration trial for refractory advanced colorectal cancer and multiple myeloma; and AEZS-108, a doxorubicin-targeted conjugate in Phase II for the treatment of ovarian, endometrial, castration refractory prostate, and refractory bladder cancer. The company?s lead endocrinology compound, AEZS-130, is an oral ghrelin antagonist in Phase III trial as a diagnostic test for adult growth hormone deficiency. Its pipeline also includes earlier-stage compounds, such as AEZS-112 that is in a Phase I trial in advanced solid tumors and lymphoma, as well as AEZS-120, an anti-cancer vaccine in pre-clinical development. The company was founded in 1991 and is headquartered in Quebec City, Canada.

Advisors' Opinion:
  • [By Sean Williams]

    High-risk, high-reward suggestions
    There's an undeniably large dollar amount being pledged to cancer research, but, even if a drug gains approval, that's no guarantee that the biotech or pharmaceutical company behind that drug will be a success. Some of the biggest gains (and losses) come from taking a leap of faith based on clinical data, or the approval of one or two drugs or devices within a pipeline. After that, it's all up to the drug or devices' effectiveness, its pricing, and the success of the marketing teams promoting the drug or device. Here are a few high-risk, high-reward names you should be keeping your eye on.

    Exelixis (NASDAQ: EXEL  ) : In November Exelixis had its first drug, known as Cometriq, approved by the Food and Drug Administration to treat metastatic medullary thyroid cancer. Although the market for this disease is pretty small -- somewhere between 500 and 700 people in the U.S. -- the near-tripling in progression-free survival, or PFS, in trials would indicate to me a strong likelihood that it could translate to success in other cancer types. In mid-stage prostate cancer trials, for instance, Cometriq was found to be particularly effective in dealing with bone metastases as a second or third-line treatment. We won't get any additional data until next year on Cometriq, but positive data on the prostate cancer front could be enough to double its share price if the PFS, compared to the placebo, is notably strong. ImmunoGen (NASDAQ: IMGN  ) : In February, Roche�and ImmunoGen received approval for Kadcyla as a secondary treatment for HER2-positive breast cancer. This is ImmunoGen's first drug approval, and it gives the company a chance to showcase what I feel is one of the future pathways of fighting cancer -- its targeted-antibody payload, or TAP, technology. ImmunoGen's TAP technology works by attaching a toxin -- in this case Roche's Herceptin -- to an antibody, and teaching that antibody to release the to
  • [By Eric Volkman]

    Aeterna Zentaris (NASDAQ: AEZS  ) has made a significant change in its executive suite and boardroom. David Dodd is now the company's chief executive and a member of its board of directors. He succeeds Juergen Engel. The firm did not provide the reasons for the succession.

  • [By Roberto Pedone]

    Aeterna Zentaris (AEZS), a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. This stock closed up 5% to $1.25 in Thursday's trading session.

    Thursday's Range: $1.19-$1.26
    52-Week Range: $0.99-$1.75
    Thursday's Volume: 1.32 million
    Three-Month Average Volume: 646,050

    From a technical perspective, AEZS ripped sharply higher here right above its 50-day moving average of $1.17 and back above its 200-day moving average of $1.22 with strong upside volume flows. This sharp spike higher on Thursday also pushed shares of AEZS into breakout territory, since the stock took out some more near-term overhead resistance at $1.23. This move is starting to push shares of AEZS within range of triggering another big breakout trade. That trade will hit if AEZS manages to take out some key overhead resistance levels at $1.28 to $1.35 with high volume.

    Traders should now look for long-biased trades in AEZS as long as it's trending above its 200-day at $1.22 or above Thursday's intraday low of $1.19 and then once it sustains a move or close above those breakout levels with volume that hits near or above 646,050 shares. If that breakout begins soon, then AEZS will set up to re-test or possibly take out its next major overhead resistance levels at $1.52 to $1.62.

  • [By Sean Williams]

    What's coming down the pipeline
    As we saw with the current treatment options, the endometrial cancer pipeline isn't filled with a lot of choices, but they are at least more encouraging than the standard care treatments we've seen over the past three decades.

    Avastin: Surprise: It's Roche's (NASDAQOTH: RHHBY  ) wonder drug yet again! Roche's Avastin is in the process of being tested as a treatment for recurrent endometrial cancer and demonstrated promising results in a mid-stage trial according to the Journal of Clinical Oncology. Avastin, which is an angiogenesis inhibitor (a fancy way of saying it inhibits blood vessel growth), was tested on 52 evaluable patients and delivered a progression-free survival of at least six months for 21 of them. Overall median PFS was 4.2 months, and median overall survival came in at 10.5 months. Don't be surprised if Roche decides to pursue further studies of Avastin in recurrent endometrial cancer with these results.� AEZS-108: Currently in late-stage development by Aeterna Zentaris (NASDAQ: AEZS  ) , a holding in my own portfolio, AEZS-108 is an intravenous treatment composed of a synthetic peptide carrier and doxorubicin that targets Luteinizing Hormone Releasing Hormone-receptor expressing tumors. That series of scientific jargon simply means it targets cancer cells with minimal healthy cell death relative to the current standards of treatment. In mid-stage trials, AEZS-108 delivered an overall response rate of 30.8% and a clinical benefit rate of 74.4%. These figures were enough to get AEZS-108 a special protocol assessment (SPA), which should streamline its approval if these results stay consistent in late-stage studies.

    Your best investment
    With very few investable options to choose from, since many of these treatments are off patent as they're decades old, I'm going to split my decision this week between Roche and Aeterna Zentaris for obvious reasons.

Hot Quality Stocks To Invest In 2014: South Jersey Industries Inc.(SJI)

South Jersey Industries, Inc., through its subsidiaries, engages in the purchase, transmission, and sale of natural gas for residential, commercial, and industrial customers. It also sells natural gas and pipeline transportation capacity on a wholesale basis to various customers on the interstate pipeline system, as well as transports natural gas purchased directly from producers or suppliers to their customers. In addition, it markets natural gas storage, commodity, and transportation assets on a wholesale basis for energy marketers, electric and gas utilities, and natural gas producers in the mid-Atlantic, Appalachian, and southern regions of the United States. Further, the company develops and operates energy-related projects, which provide cooling, heating, and emergency power; and operates landfill gas-fired electric production facilities and solar projects. Additionally, it provides services for the acquisition and transportation of natural gas and electricity for re tail end users; markets total energy management services; installs and services residential and light commercial HVAC systems; provides plumbing services; and services appliances, as well as offers meter reading services. As of December 31, 2010, the company served 347,725 residential, commercial, and industrial customers primarily in southern New Jersey. The company was founded in 1910 and is headquartered in Folsom, New Jersey.

Advisors' Opinion:
  • [By Marc Bastow]

    Energy services holding company South Jersey Industries (SJI) raised its quarterly dividend 6.7% to 47.25 cents per share, payable on Dec. 27 to shareholders of record as of Dec. 10. The increase marks the 15th consecutive increase to the annual dividend.
    SJI Dividend Yield: 3.41%

Hot Quality Stocks To Invest In 2014: Kate Spade & Co (KATE)

Kate Spade & Co, formerly Fifth & Pacific Companies Inc, incorporated in January 1976, designs and markets a portfolio of retail-based, premium brands, including JUICY COUTURE, KATE SPADE and LUCKY BRAND. The Company also has a private brand jewelry design and development division, which markets brands through department stores and serves J.C. Penney Corporation, Inc. (JCPenney), through exclusive supplier agreements for the LIZ CLAIBORNE and MONET jewelry lines and Kohl's Corporation (Kohl's) through an exclusive supplier agreement for DANA BUCHMAN jewelry. It also has licenses for the LIZ CLAIBORNE NEW YORK brand, available at QVC and LIZWEAR, which is distributed through the club store channel. It maintains an 18.75% stake in MEXX, a European and Canadian apparel and accessories retail-based brand. As of December 31, 2011, the Company operated a total of 307 specialty retail stores under various Company trademarks, consisting of 285 retail stores within the United States and 22 retail stores outside of the United States (primarily in Europe and Canada). The Company operates in four segments: JUICY COUTURE segment, KATE SPADE segment, LUCKY BRAND segment, and Adelington Design Group & Other segment. In August 2013, Granite Real Estate Investment Trust closed its acquisition of a 600,000 square foot logistics-distribution facility in West Chester (Cincinnati), Ohio from the Company. In February 2014, the Company completed the sale of Lucky Brand Dungarees Inc.

JUICY COUTURE segment consists of the specialty retail, outlet, concession, wholesale apparel, wholesale non-apparel (including accessories, jewelry and handbags), e-commerce and licensing operations of its JUICY COUTURE brand. KATE SPADE segment consists of the specialty retail, outlet, wholesale apparel, wholesale non-apparel, e-commerce and licensing operations of its KATE SPADE and JACK SPADE brands. LUCKY BRAND segment consists of the specialty retail, outlet, wholesale apparel, wholesale non-apparel, e-commerce and licensing ! operations of its LUCKY BRAND. Adelington Design Group & Other segment consists of exclusive arrangements to supply jewelry for the DANA BUCHMAN, LIZ CLAIBORNE and MONET brands; the wholesale non-apparel operations of the TRIFARI brand and licensed KENSIE brand; the wholesale apparel and wholesale non-apparel operations of the licensed LIZWEAR brand and other brands, and the licensed LIZ CLAIBORNE NEW YORK brand.

JUICY COUTURE

The Company�� JUICY COUTURE brand offers luxurious, casual and fun women's and girl's apparel, as well as accessories and jewelry under various JUICY COUTURE trademarks. JUICY COUTURE products are sold through wholly owned specialty retail and outlet stores, select upscale specialty retail stores and department stores throughout the United States, through a network of distributors and owned and licensed retail stores in Asia, Canada, Europe, South America and the Middle East, as well as through its JUICY COUTURE e-commerce Website. In addition, JUICY COUTURE has existing licensing agreements for fragrances, footwear, optics, watches, swimwear, electronics cases and baby products.

KATE SPADE

The Company�� KATE SPADE brand offers fashion products (accessories, apparel and jewelry) for women and men under the KATE SPADE and JACK SPADE respectively. These products are sold primarily in the United States through wholly owned specialty retail and outlet stores, select specialty retail and upscale department stores, its operations in Brazil and the United Kingdom and through its KATE SPADE e-commerce Website, as well as through joint ventures in Japan and China and through a network of distributors in Asia. KATE SPADE's product line includes handbags, small leather goods, fashion accessories, jewelry and apparel. In addition, KATE SPADE has licensing agreements for footwear, optics, fragrances, tabletop products, legwear, electronics cases, bedding and stationery. JACK SPADE products include briefcases, travel bags, small leather go! ods and a! pparel.

LUCKY BRAND

The Company�� LUCKY BRAND offers an expanded assortment of men's and women's denim, woven and knit tops, dresses and sweaters, graphic tees, as well as accessories and jewelry, under various LUCKY BRAND. LUCKY BRAND products are available for sale at wholly owned specialty retail and outlet stores in the United States and Canada, select department and specialty stores and through the LUCKY BRAND e-commerce Website. LUCKY BRAND also has licensing agreements for fragrances, footwear, swimwear, eyewear and electronic cases.

Adelington Design Group & Other

The operations within the Company Adelington Design Group & Other segment consist of exclusive supplier arrangements to provide JCPenney with LIZ CLAIBORNE and MONET branded jewelry and Kohl's with DANA BUCHMAN-branded jewelry for two years; a license to produce and sell jewelry under the KENSIE brand name; a royalty free license for the LIZ CLAIBORNE NEW YORK brand; LIZWEAR, women's apparel available through the club store channel, and TRIFARI, a signature jewelry brand for women sold in mid-tier department stores.

The Company competes with Marc by Marc Jacobs, JCrew, Michael Kors, Pink, Coach, Diane von Furstenberg, Diesel, Guess, True Religion, 7 for all Mankind, Abercrombie & Fitch, and Tory Burch.

Advisors' Opinion:
  • [By U.S. News]

    Linda Davidson/The Washington Post via Getty ImagesShoppers at the Tanger Outlet Mall in Oxon Hill, Md. There are few forms of shopping I enjoy more than outlet shopping. There is something about all of those discount stores packed so closely together that makes me super excited! But I am not going to tell you that all outlet stores are a good deal, because some of them are not. Also, brands sometimes create cheaper items to sell specifically in their outlet locations, and those are not always a smart buy. But for the most part, outlet malls are still an excellent way to save some money while picking up items for the entire family. Here are five ways to make the most of your trip to an outlet: 1. Figure out the outlet 'brand.' There are a couple of management companies that own quite a few outlet malls in the United States, including Premium Outlets (SPG) and Tanger Factory Outlet Centers (SKT). Before heading out, be sure to check the website for the entire outlet mall for any possible deals or coupons. Premium and Tanger Outlets also have Facebook (FB) pages where they will occasionally post coupons that you can print from home. 2. Look for an outlet discount card or VIP program. Many outlet malls have VIP savings programs that can save you big bucks throughout the year and also give you special access to new promotions and sales. The Fashion Outlets of Chicago opened last year and offer a Green Savings Card that costs $5 for a yearly membership. Those with a Green Savings Card receive extra discounts at a huge number of stores and restaurants in the mall, which is on top of the already low prices. 3. 'Like' the outlet store on Facebook. If there is an outlet store that you frequent, go ahead and like its Facebook page so that you will be one of the first to know about sales and promotions. The Kate Spade Outlet (KATE) will frequently post promotions to Facebook before emailing subscribers. The J. Crew Factory Store has offered special promotions th

Hot Quality Stocks To Invest In 2014: Dean Foods Company(DF)

Dean Foods Company, together with its subsidiaries, operates as a food and beverage company in the United States. It operates in two segments, Fresh Dairy Direct-Morningstar and WhiteWave-Alpro. The Fresh Dairy Direct-Morningstar segment manufactures, markets, and distributes various branded and private label dairy case products, including cream, ice cream mix, and ice cream novelties; creamers and other extended shelf life fluids; yogurt, cottage cheeses, sour creams, and dairy-based dips; fruit juices, fruit-flavored drinks, iced teas, and water; half-and-half and whipping creams; and items for resale, such as butter, cheese, eggs, and milk shakes. This segment sells its dairy case products to retailers, distributors, foodservice outlets, educational institutions, and governmental entities. The WhiteWave-Alpro segment manufactures, develops, markets, and sells various branded dairy and dairy-related products, such as milk and other dairy products; organic dairy products; plant-based beverages, such as soy, almond, and coconut milks; and soy food products, coffee creamers, and creamers and fluid dairy products. It also provides branded soy-based beverages and food products in Europe under the Alpro and Provamel brands. This segment sells its products to various customers, including grocery stores, club stores, natural foods stores, mass merchandisers, convenience stores, drug stores, and foodservice outlets. The company was formerly known as Suiza Foods Corporation and changed its name to Dean Foods Company on December 21, 2001 as a result of merger between the former Dean Foods Company and Suiza Foods Corporation. Dean Foods Company was founded in 1995 and is headquartered in Dallas, Texas.

Advisors' Opinion:
  • [By Johanna Bennett]

    Whys is Dean Foods (DF) having such a bad day? Well, blame someof it on�all those milk drinkers in New Zealand.

    Dean reported a wider-than-expected second-quarter loss and warned it will post another loss in the third quarter. For the period ended June 30, Dean posted an operating loss of 14 cents a share, compared with 26 cents a share 12 months ago. The company had expected a loss of 2 cents to 8 cents a share. Net sales climbed 7.5% to $2.39 billion.

    Why the�dire quarter? The largest milk producer in the U.S. is struggling with surging costs for the raw milk it buys from farmers casued by�heavy�overseas demand for U.S. dairy products and last year’s drop in�production in�New Zealand and other�big dairy producing cuntries. Dean added that it faced difficulty passing on the higher costs because it risked lower sales volumes at supermarkets, where sales trends have been weak amid a year-long decline in milk consumption.

    As of the closing bell, Dean Foods had fallen almost 4% to end the day at $15.19

  • [By Michael Lewis]

    After being spun off from its parent company, Dean Foods (NYSE: DF  ) , health-oriented food purveyor White Wave Foods (NYSE: WWAV  ) offered the market a nearly pure play on plant-based food items, one of the fastest growing areas within the industry. The spinoff was originally priced rather high, though the company is certainly growing. Now, the secondary offering is coming to a close and the spinoff is nearly complete while the company posts strong preliminary results. Even at its premium price, is White Wave Foods a buy after the spin-off is completed?

  • [By Tim Brugger]

    Deans Foods (NYSE: DF  ) has set a public offering price of $17.75 per share for approximately 29.9 million shares of WhiteWave Foods, a wholly owned subsidiary of Deans Foods, according to a recent press release. The intention to spin-off WhiteWave was first announced May 1, 2013.

  • [By Rich Duprey]

    And it's pitting dairy producers against soda makers. The industry's biggest dairy company, Dean Foods (NYSE: DF  ) , says that even though�about half the sugar in flavored milk is from naturally occurring lactose,�all�the sugar in soda is added sugar.

Hot Quality Stocks To Invest In 2014: Barclays PLC (GRN)

Barclays PLC (Barclays) is a global financial services provider engaged in retail banking, credit cards, wholesale banking, investment banking, wealth management and investment management services. The Company�� operations include its overseas offices, subsidiaries and associates. The Company operates in eight segments: UK Retail and Business Banking (UK RBB), Europe Retail and Business Banking (Europe RBB), Africa Retail and Business Banking (Africa RBB), Barclaycard, Barclays Investment Bank, Barclays Corporate Banking, Wealth and Investment Management, and Head Office and Other Operations. Advisors' Opinion:
  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, the iPath Global Carbon ETN (NYSEMKT: GRN  ) has received the dreaded one-star ranking.

  • [By Todd Shriber, ETF Professor]

    Big losers (down at least 5%): Direxion Daily Gold Miners Bear 3X Shares (NYSE: DUST), iPath Global Carbon ETN (NYSE: GRN), iShares MSCI Emerging Markets Value ETF (NYSE: EVAL) and the PureFunds ISE Mining Service ETF (NYSE: MSXX).

  • [By Todd Shriber, ETF Professor]

    Big winners (up at least 5%): VelocityShares 3x Inverse Natural Gas ETN (NYSE: DGAZ), iPath Global Carbon ETN (NYSE: GRN), ProShares UltraShort DJ-UBS Natural Gas (NYSE: KOLD) and the ProShares MSCI UltraShort Mexico (NYSE: SMK).

No comments:

Post a Comment